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Objective: To analyze the clinical profile of patients admitted 
to the intensive care unit (ICU) of Manipal Teaching Hospital 
(MTH) at Pokhara, Nepal, identify the commonly prescribed 
drugs, drug categories, dosage forms, antimicrobials, 
sensitivity pattern of antimicrobials and the treatment 
outcomes. 
Materials and Methods: A cross sectional, descriptive study in 
which he case records of all the patients admitted in the ICU 
during 1st August to 30th September, 2007 were collected and 
the details were entered in the patient profile form. The filled 
patient profile forms were retrospectively analyzed as per the 
study objectives.     
Results: Altogether, 201 patients [males 101 (50.25%)] were 
admitted. Most common diagnosis was ‘Myocardial Infarction 
/Ischemic heart disease’ [13.96 % (n=62)]. The median 
(interquartile range) of the ICU stay was 3 (2-4) days. 
Cardiovascular drugs [31.7% (n=761) were the most 
commonly prescribed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Among the antimicrobials, metronidazole was most 
commonly prescribed followed by ceftriaxone.  The 
morality rate in the ICU was 17.41 % and the major causes 
of mortality were cardiovascular and respiratory diseases.      
Conclusion: Antimicrobials was the most common drug 
category used in the ICU and ‘pantoprazole’ was the most 
commonly prescribed individual drug. Cardiovascular and 
respiratory diseases were major causes of death in the 
ICU.  
 
 
Irrational use of drug is a common problem 
worldwide [1-4]. Studies from Nepal have acknowledged 
irrational use of medicines [5-8]. One of the places where 
irrational drug use is common is the intensive care unit 
(ICU). Since most of the patients in the ICUs are critically 
ill and often suffer from multiple complications, 
polypharmacy becomes unavoidable. Studies from 
different countries have acknowledged irrational drug use 
in the ICUs and recommended interventions to improve 
the drug use pattern [9-11]. Previous studies carried out 
in the ICU of Manipal Teaching Hospital (MTH), Pokhara, 
Nepal have identified discrepancies in drug use and 
recommended improvements [12,13]. From the year 2004 
onwards several initiatives were taken in MTH to improve 
the drug use pattern in the hospital [14,15]. Some of these 
include establishment of drug information center, 
strengthening of hospital drug and therapeutics 
committee, banning of certain irrational drug 
combinations etc.  Moreover several initiatives were also 
taken to improve the functioning of the ICU.  
Periodic studies on drug utilization can be useful to 
know the use pattern, early signals of irrational use of 
drugs, help to carry out interventions to improve drug 
use, increase the quality control cycle and continuous 
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quality improvement [16]. Similarly periodic evaluation of the 
clinical profile of the patients gives an idea regarding the 
morbidity and mortality profile and also provides room for 
improvements. A previous study from MTH has provided some 
data regarding the drug use pattern in ICU.  But that study was 
focused mainly on utilization pattern of antimicrobials [13]. 
The present study in addition to the utilization of 
antimicrobials also studied parameters like clinical profile of 
the patients, treatment outcomes etc. Moreover the previous 
study was more than five years old. With this background the 
present study was carried out to study the demographic details 
of patients admitted in the intensive care unit, to identify the 
commonly used drug classes, individual drugs and dosage 
forms used in the intensive care unit and to study the 
commonly used antimicrobials along with their sensitivity 
pattern and the treatment outcomes of the admitted patients.   
 
 
Study design 
Cross sectional, descriptive study. The patients’ files were 
checked at the time of discharge from the ICU and the data 
were entered in a patient profile form designed for this study.    
Study site 
ICU of MTH, a 750 bedded tertiary care teaching hospital 
located in Pokhara, western Nepal. The hospital has got several 
clinical and paraclincial departments. The hospital has an 
eleven bedded ICU.  Since there is no separate cardiac care 
unit, even cardiac patients are admitted in the ICU.  The 
hospital caters the healthcare needs of ‘Western region’ of 
Nepal that has a population of approximately 3 million. On an 
average nearly fifty patients get admitted to the MTH.  
Study duration 
Two months (from 1st August till 30th September, 2007).    
Tools used 
A patient profile form was used to collect the data as per the 
study objectives.  This form was designed by the researchers 
for the purpose of this study.  
Inclusion and exclusion criteria 
All the patients who were admitted in the ICU during the study 
period were included in the study.  
Ethical approval 
Since the study did not interfere with the patient care and 
disclose any confidential findings, we did not obtain an ethical 
approval.  
Operational modality 
The researchers prospectively collected the patient case 
records and collected the details and entered in the patient 
profile form. The filled patient profile forms were analyzed as 
per the study objectives. The parameters analyzed were the 
age and sex distribution of the study patients, diagnosis, 
duration of ICU stay, therapeutic category of the drugs 
prescribed, commonly prescribed drugs, commonly used 
antimicrobials, dosage forms of the drugs used and the 
treatment outcomes.  
Data analysis 
The data was entered in the Microsoft excel spread sheet and 
analyzed descriptively. The SPSS version 9.0 was used to carry 
out the descriptive statistics.  
 
 
 
All together 201 patients were admitted in the ICU during 
the study period. The males were 101 (50.25%) and 
females were 100 (49.75%).  Total 10 (4.98%) of the 
patients were within 20 years of age and 25 (12.44%) 
were of age group 21-40 years, 50 (24.88%) were 41-60 
years, and 112 (55.72%) were above 60 years. The age 
details of 4 (1.99%) of the patients was not available.  
Diagnosis of the patients 
The most common diagnosis of the patients admitted in 
the ICU was MI/IHD accounting for 13.96 % of the total 
cases. The details regarding the diagnoses are listed in 
Table 1.          
Duration of stay in the intensive care unit (n=201) 
 The median interquartile range of the duration of the 
hospital stay was 3 (2-4) days. A total of 42.29% (n=85) 
patients stayed for 1-2 days, 34.22% (n=69) for 3-4 days, 
15.42% (n=31) for 5-6 days, 1.99 % (n=4) for 7-8 days 
and 1.99% (n=4) for more than 8 days. The duration of 
stay of 3.98% (n=8) patients were not known.   
Therapeutic category of the drugs used 
 Altogether 2401 drugs were prescribed with an average 
of 11. 94 drugs per patients. The most commonly used 
drugs were cardiovascular drugs accounting for 31.7% 
(n=761). The details are listed in Table 2.          
Top ten antimicrobials 
The top ten commonly used antimicrobials were analyzed 
and the details are listed in Table 3.  
Antibiogram of the isolates from ICU 
During the study period a total of 30 sputum samples, 17 
urine samples and 11 blood samples were sent for culture 
sensitivity.  Out of which organisms were isolated from 21 
sputum samples, 7 urine samples and 2 blood samples. 
The antimicrobial sensitivity of the pathogens in the ICU 
was studied and the details are listed in Table 4.    
Dosage form of the drugs used (n=2401) 
The most commonly used dosage form was tablets 
47.81% (n=1148) followed by injections 33.11% (n=795), 
intravenous fluids 7.755 (n=186), syrups 5.50% (n=132), 
nebulized solutions 2.21 (n =53), capsules 1.54% (n=53), 
eye/ear drops 0.54% (n=13), powders 0.46%(n=11), dry 
powder inhalers 0.29% (n=7), ointments 0.17% (n=4), 
metered dose inhalers 0.12% (n=3), cream/gargles/gels 
0.20% (n=5) and the dosage forms of 0.29% (n=7) 
preparations were unknown.   
Top twenty drugs used in the ICU 
Pantoprazole was the most commonly prescribed drugs. 
The details regarding the top twenty commonly used 
drugs are listed in Table 5.                 
Treatment outcomes 
The mortality rate in the ICU was 17.41 % (n=35).   A total 
of 56.22 %(n=113) patients improved, 4.98% (n=10) 
patient did not improve or were static in their progress 
and 9.45%(n=19) patients left against medical advice. The 
details regarding the outcome of 11.94% (n=24) of the 
patients were not known.   
Causes of death in the ICU 
Altogether 35 patients expired in the ICU. The most 
Materials and Methods 
 
Results  
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common cause of mortality in the ICU was cardiovascular 
diseases 22.86 % (n= 8) and respiratory diseases (22.86% 
(n=8) followed by neurological disorders 17.14% (n=6).   
 
 
The present study evaluated the utilization of drugs in the ICU 
of MTH. ICU is a special setting wherein patients with serious 
complications and multiple complications get treated. The use 
of drugs is thus expected to be high. Altogether 201 patients 
were admitted in the ICU during the study period with an 
almost equal sex distribution. We found more than fifty 
percent of the patients to be aged more than 60 years.  The 
previous studies from our ICU also documented a high 
percentage of elderly patients [12,13].  It is because the 
common diseases managed in the ICU like myocardial 
infarction, ischemic heart disease etc occur in the elderly 
patients. It is because the hospital do not have a separate CCU 
and hence patients with cardiac complications are also 
managed in the ICU. However, a CCU is expected to come up in 
the near future.     
The average number of drugs used in the ICU per patient was 
11. 94. It is well known that elderly patients are suffering from 
multiple diseases and are prescribed a large number of drugs 
[17,18]. Polypharmacy increases the risk of drug-drug 
interactions [19,20]. A previous study from the internal 
medicine wards and ICU of our hospital identified a high risk 
for potential DDIs [21].  Added to these, the average number of 
drugs use din the ICU has also increased dramatically to 11.94 
in the present study from the previous value of 5.15  2.67 
suggesting an increase [12].  In general it is better to keep the 
number of drugs as low as possible to minimize the risk for 
DDIs and also to minimize the economic burden on the patient.     
The most common condition managed in our ICU was MI/IHD, 
followed by infections.  Due to urbanization and rapid lifestyle 
changes there has been an increase in the incidence of 
cardiovascular diseases in developing countries. Lifestyle 
modifications can play an important role in preventing and 
managing these cardiovascular diseases.  However, in our 
previous study the most common disease managed was COPD 
[13]. In general patients with cardiovascular diseases are 
prescribed a higher number of drugs. This might be one of the 
reasons for the increase in the number of drugs prescribed.  
The recent national mortality report also suggests respiratory 
diseases as the major cause of death in the country [22]. In our 
ICU there is less number of patients with respiratory diseases 
because most of the COPD cases are managed in a semi 
ICU/COPD block with facility for central oxygen supply and 
monitoring by the nurses and doctors. Though the number of 
respiratory cases managed in the ICU has decreased compared 
to that reported in previous studies it still was the major cause 
of mortality in the ICU suggesting a significant burden.  It may 
be because out hospital is a tertiary care center due to which 
many terminal COPD cases are being referred and managed in 
ICU.  
The most common class of drugs prescribed was 
antibiotics/antibacterials. Among this class the most 
commonly prescribed drug was metronidazole. Metronidazole 
is used in most of the cases of suspected aspiration pneumonia 
as most of the unconscious patients when brought to the 
hospital have a history of aspiration, especially in stroke 
patients. Antimicrobial resistance is a common problem 
worldwide [23-25]. The culture and sensitivity reports of 
our ICU reports a high number of Pseudomonas species  
suggesting the need for antipseudomonal drugs like 
ceftazidime. Amoxicillin/clavulanic acid combination is 
used widely in the ICU in cases of acute exacerbation of 
COPD since the conventional antimicrobials like 
ampicillin, amoxicillin etc. are insensitive against the 
betalactamase producing species of Streptococcus 
pneumonia. However, one should look for cheaper 
alternatives such as ‘aminoglycosides with ampilcillin’  
etc. considering the cost and sensitivity pattern). Some of 
the strategies that can be used to minimize the occurrence 
of antimicrobial resistance are prescribing the 
antimicrobials for the correct duration, at the correct dose 
and by cycling of antibiotics [26]. In our ICU some of the 
strategies followed are regular fumigation of the ICU, 
empirical therapy till confirmation of the organism by the 
culture sensitivity reports. However, there is a need for 
improvement in terms of regular hand washing by the 
healthcare professionals and the need for an antibiotic 
policy.  For the past two years the Drug Information 
Bulletin (DIB) of our hospital publishes the microbial 
sensitivity pattern of the commonly isolated organisms in 
the hospital [27]. This initiative may be useful in knowing 
about the sensitivity pattern of the organisms and 
prescribing antimicrobials accordingly. This can also 
guide the prescriber on empirical therapy with 
antimicrobials till the culture sensitivity report is made 
available.    
The top ten drugs used in the ICU were studied and it was 
found that pantoprazole was most commonly prescribed. 
In the previous study ranitidine was one among the top 
ten drugs used [13]. At present ranitidine is being 
replaced by pantoprazole. A recent study from the United 
States assessed intermittent IV pantoprazole for control of 
gastric acid and the possible prevention of upper 
gastrointestinal (UGI) bleeding in ICU patients. The study 
concluded that intermittent IV pantoprazole effectively 
controls gastric pH and may protect against UGI bleeding 
in high risk ICU patients without the development of 
tolerance [28]. Preliminary findings have shown that 
intermittent administration of intravenous pantoprazole, 
is as effective in raising intragastric pH on the first day as 
a continuous infusion of a histamine-2-receptor 
antagonist in clinical trials conducted within an ICU 
setting [29]. Another study compared the efficacy, safety, 
and cost of using cimetidine, famotidine, and lansoprazole 
(proton pump inhibitor) for stress ulcer prophylaxis. The 
study found lansoprazole to be the most cost-effective 
therapy [30]. However, one should keep in mind the cost 
of PPIs in comparison with ranitidine. In general, therapy 
with PPIs is much costlier than with H1-blockers.  
Considering the cost-beneficial outcomes, one should be 
prudent in prescribing PPIs since it may add to the 
economic burden to the patients.  
   
The mortality rate in our ICU was 17.41%. The major 
Discussion  
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causes of death on our ICU were cardiovascular diseases and 
respiratory diseases followed by neurological disorders. In the 
previous study from our ICU, the mortality rate was 15.4% 
[13].  Since the duration of the study is low it is difficult to 
compare our value with the previous study.   
 
 
Our study had a few limitations. The study duration was low (2 
months). We also did not follow up of the patients once they 
are discharged from the ICU. In the absence of established 
treatment guidelines the rationality of use of particular drugs 
could not be determined.    
 
 
The study was successful in identifying the pattern of drug use 
in the ICU. Antimicrobials were the most common class of 
drugs used. Pantoprazole was the most commonly prescribed 
individual drug. The most common diseases managed were 
cardiovascular problems followed by infections. 
Cardiovascular and respiratory diseases were the major causes 
of mortality. The average number of drugs per prescription has 
increased considerably compared to the past.  The overall use 
of antimicrobials in the ICU is justifiable as most of the 
economic and older drugs are still prescribed. The use of PPIs 
needs to be looked upon and interventions may be needed.    
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Table 1 Diagnosis of the patients (444) 
    Diagnosis Number Percentage 
Myocardial infarction/Ischemic heart disease   62 13.96 
Infections   48 10.81 
Cerebrovascular accident  40 9.01 
Hypertension (Uncontrolled 
/emergency/urgency)  
29 
6.53 
Arrhythmia/ conduction disturbances  27 6.08 
Alcoholic liver disease /other liver diseases 23 5.18 
Acute exacerbation of COPD / respiratory failure  18 4.05 
Congestive cardiac failure/ dilated 
cardiomyopathy  
18 
4.05 
Renal failure/ dyselectrolytemia 18 4.05 
Diabetes mellitus/diabetic ketoacidosis  17 3.83 
Primary central nervous system disease 11 2.48 
Poisoning/snake bite 9 2.03 
Malignancy 7 1.58 
Bleeding/shock 7 1.58 
Anemia 6 1.35 
Head injury 3 0.68 
Psychosis 2 0.45 
Miscellaneous  99 
22.30 
Note: One patient might have had more than one diagnosis 
  
Table 2  Therapeutic category of the drugs used (n=2401) 
  Therapeutic classification No. of drugs   Percentage  
Cardiovascular drugs   761 31.7 
Antimicrobials   353 14.7 
Drugs acting on the gastrointestinal tract  338 14.08 
Drugs acting on the central nervous system  179 7.46 
Intravenous fluids  179 7.46 
Antiasthmatics  100 4.16 
Vitamins, minerals and dietary supplements 95 3.96 
Diuretics 95 3.96 
Analgesics and anti-inflammatory  68 2.83 
Electrolytes  40 1.67 
Antihistamines  38 1.58 
Antidiabetics  29 1.21 
Unknown 6 0.25 
Miscellaneous  120 5 
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Table 3 Top ten commonly used antimicrobials 
Antimicrobials No. of drugs 
Metronidazole  91 
Ceftriaxone 36 
Amoxicillin+ Clavulanic acid  32 
Ampicillin 29 
Ciprofloxacin  22 
Ceftazidime 19 
Cefotaxime 18 
Azithromicin  12 
Amikacin 8 
Cefpodoxime   8 
Ofloxacin      8  
 
 
 
 
 
 
 
Table 4 Antibiogram of the isolates 
Specimen Organisms Sensitivity pattern 
Sputum  (21/30) P. aereuginosa        (14) Ciprofloxacin         (8/14) 
Aminoglycosides   (11/14) 
Carbenicillin           (14/14) 
Imipenem               (14/14) 
Acinetobacter Sp      (4) Aminoglycosides    (2/4) 
Carbenicillin            (2/4) 
Imipenem                (4/4) 
Kleibsella Sp              (2) - 
H. influenza                (1) - 
Urine (7/17) E.coli                          (5) Ciprofloxacin           (4/5) 
Aminoglycoside       (5/5) 
Nitrofurantoin          (5/5) 
Kleibsella Sp               (1) - 
Acinetobacter Sp          (1) - 
Blood  (2/11 ) P. aeruginosa              (2) Only sensitive to Imipenem 
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Table 5 Top twenty drugs used in the ICU              
Name of drug Number ATC code  
Pantoprazole 173 BO1AC06 
Clopidogrel 112 - 
Aspirin 110 A12CAO1/ BO5CBO1/  BO5XAO3 
Normal saline  97 BO1AC06/ NO2BA01 
Metronidazole  91 CO9BAA02 
Enalapril 80 RO1AXO3/ RO3BB01 
Atorvastatin 67 C10AA05  
Frusemide  61 
AO1AB17/ DO6BXO1/ GO1AFO1/  
JO1XDO1/ PO1ABO1 
Isosorbide mononitrate 60 C01DA14   
Dextrose + normal saline  55 CO3CAO1 
Metoprolol 45 C07AB02  
Enoxaparin  44 B01AB05  
Alprazolam 42 N05BA12 
Lactulose 40 A06AD11 
Cremaffin 39 - 
Ipratropium 39 AO2BCO2 
Isosorbide dinitrate  37 C01DA08/ CO5AE02  
Ceftriaxone 36 J01DD04 
Vitamin K 31 -   
Ranitidine  30  A02BA02 
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